Pontifax traces its founding to Teva chairman Eli Hurvitz's vision and, unlike VCs that only back outside startups, both creates its own life-sciences companies and partners with outside management teams; one early result was turning a $3.8M investment in Kite Pharma into $130M after Gilead's acquisition, and the firm has since built board experience across biotech exits to Gilead, Merck, and Lilly, including founding Keros Therapeutics. Beyond healthcare, Pontifax runs a separate agrifood fund, Pontifax AgTech, based in Santa Monica, which invested in Blue River Technology before John Deere acquired it for $305M.